A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors

A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors

Background and Objectives Immune checkpoint inhibitors (ICIs) are effective in various types of cancer and cause immune-related adverse events (irAEs). The occurrence of irAEs is associated with improved survival outcome. We investigated the association between the occurrence of irAEs and overall su...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Hiroki Hata MS, Chikako Matsumura PhD, Yugo Chisaki PhD, Kae Nishioka, Misaki Tokuda, Kazuyo Miyagi, Tomoki Suizu MS, Yoshitaka Yano PhD
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	SAGE Publishing 2022-09-01
Цуврал:	Cancer Control
Онлайн хандалт:	https://doi.org/10.1177/10732748221130576

Ижил төстэй зүйлс

Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey
-н: Hiroki Hata MS, зэрэг
Хэвлэсэн: (2020-12-01)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
-н: Hideo Oishi, MD, зэрэг
Хэвлэсэн: (2020-10-01)

Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
-н: Arthur E. Frankel MD, зэрэг
Хэвлэсэн: (2019-04-01)

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
-н: Taichi Miyawaki, MD, зэрэг
Хэвлэсэн: (2020-06-01)

Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosisCentral MessagePerspective
-н: Bilguun Erkhem-Ochir, MD, зэрэг
Хэвлэсэн: (2021-03-01)

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
-н: Samit Chatterjee PhD, зэрэг
Хэвлэсэн: (2017-07-01)

Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade
-н: Tara Davidson, MD, зэрэг
Хэвлэсэн: (2022-07-01)

Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study
-н: Chenxing Zhang, PhD, зэрэг
Хэвлэсэн: (2020-03-01)

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma
-н: Daisuke Hazama, MD, PhD, зэрэг
Хэвлэсэн: (2024-01-01)

A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisNovel Teaching Points
-н: Tatsuya Nishikawa, MD, PhD, зэрэг
Хэвлэсэн: (2022-07-01)

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
-н: Kenji Morimoto, MD, PhD, зэрэг
Хэвлэсэн: (2022-09-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
-н: Mariana Mirabel, MD, PhD, зэрэг
Хэвлэсэн: (2020-09-01)

A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
-н: Alan Guillermo Alejandre Gonzalez PhD, зэрэг
Хэвлэсэн: (2023-05-01)

A Common Pituitary Autoantibody in Two Patients with Immune Checkpoint Inhibitor-Mediated Hypophysitis: ZCCHC8
-н: Amanda Leiter, MD, MSCR, зэрэг
Хэвлэсэн: (2020-07-01)

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
-н: Yasunori Murata, MD, PhD, зэрэг
Хэвлэсэн: (2023-12-01)

The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study
-н: Fatih Kus MD, зэрэг
Хэвлэсэн: (2024-09-01)

Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis
-н: Shiting Xu, MD, зэрэг
Хэвлэсэн: (2022-04-01)

Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC
-н: Yuto Terashima, MD, зэрэг
Хэвлэсэн: (2023-11-01)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
-н: Xinlun Dai MD, зэрэг
Хэвлэсэн: (2020-08-01)

Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis
-н: Lianghui Zhang MS, зэрэг
Хэвлэсэн: (2024-08-01)

A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis
-н: Mahdieh Azizi, PhD, зэрэг
Хэвлэсэн: (2024-01-01)

Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma
-н: Qiang Liu PhD, зэрэг
Хэвлэсэн: (2024-04-01)

Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes
-н: Etienne Charpentier, MD, зэрэг
Хэвлэсэн: (2024-01-01)

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
-н: Jack M. Qian, MD, зэрэг
Хэвлэсэн: (2022-03-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
-н: Mandy Jongbloed, MD, зэрэг
Хэвлэсэн: (2025-03-01)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors∗
-н: Dorothy M. Gujral, PhD, зэрэг
Хэвлэсэн: (2020-02-01)

A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma
-н: Ying Teng PhD, зэрэг
Хэвлэсэн: (2022-03-01)

IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
-н: Tristan V.M. Bruijn, MD, зэрэг
Хэвлэсэн: (2024-05-01)

Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
-н: Kana Hashimoto, MD, зэрэг
Хэвлэсэн: (2024-11-01)

IL-23 inhibitor treatment of immune checkpoint inhibitor-associated psoriasis: Case series and review of literature
-н: Natalie Bourand, MS, зэрэг
Хэвлэсэн: (2025-02-01)

Inhibits Murine Leukemia WEHI-3 Cells and Promotes Immune Response In Vivo
-н: Hsin-Ling Yang PhD, зэрэг
Хэвлэсэн: (2017-09-01)

Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
-н: Roger Y. Kim, MD, зэрэг
Хэвлэсэн: (2021-06-01)

Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
-н: Benjamin M.P. Elyan, MBChB, зэрэг
Хэвлэсэн: (2023-07-01)

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey
-н: Marco Tagliamento, MD, зэрэг
Хэвлэсэн: (2023-01-01)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
-н: Denis L. Jardim MD, PhD, зэрэг
Хэвлэсэн: (2018-12-01)

Seeking “protective” and “harmful” immune genes during chronic HIV-1 infection by transcriptome analysis
-н: Lingyan Zhu, PhD, зэрэг
Хэвлэсэн: (2018-09-01)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
-н: Alicia Quilez, MD, зэрэг
Хэвлэсэн: (2020-03-01)

Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation
-н: Jia-Jun Wu, MD, зэрэг
Хэвлэсэн: (2022-06-01)

The Value of Combined Detection of Megakaryocyte and Platelet Parameters for the Diagnosis of Primary Immune Thrombocytopenia
-н: Weiwei Wang MS, зэрэг
Хэвлэсэн: (2022-08-01)

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade
-н: Sakeena Fatima, BA, зэрэг
Хэвлэсэн: (2018-04-01)